BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2007
View Archived Issues
Safety and immunogenicity of new oral vaccine against enterotoxigenic E. coli demonstrated in humans
Read More
Novel nanoparticle-based technology ensures effective delivery of therapeutic siRNA in vivo
Read More
Dose-escalation trial to establish optimal dose of AL-02
Read More
Recent patents disclose novel treatment options for cardiovascular disorders
Read More
Recent University of Pittsburgh patent reports novel diagnostic agents for Alzheimer's disease
Read More
Recent patents impart new therapeutic agents for cancer
Read More
Incyte recaps active quarter
Read More
Organon's natural estrogen contraceptive enters phase III trials
Read More
Update on Peptech and EvoGenix merger
Read More
Phase III Revlimid trial halted based on positive findings
Read More
Telomerase activator shows beneficial effects on human aging
Read More
Cyto Pulse and KCC develop DNA vaccine for prostate application
Read More
Tsumura discontinues development of TU-025 in U.S.
Read More
Patient enrollment completed in phase III trial of pirfenidone in IPF patients
Read More
Medarex and Organon announce therapeutic antibody collaboration
Read More
QuatRx licenses becocalcidiol to CollaGenex
Read More
Next-generation nasal spray flu vaccine enters phase I trial
Read More
CF-101 enters clinic for third therapeutic indication
Read More
Efficacy and MOA of BioLineRx's BL-1020 for schizophrenia sought in clinic
Read More
Fast track designation received for romidepsin
Read More
Sirion commences phase III evaluation of two of its compounds
Read More
Tapestry Pharmaceuticals reports update on next-generation taxane
Read More
